DENISE VEGA: Open Payments
NPI 1962721779 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,633 in 65 payments from 15 companies in 2025. Trend: 2023 $1,657 · 2024 $2,257 · 2025 $1,633
Food & beverage: $1,633
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $305 |
| E.R. Squibb & Sons, L.L.C. | 9 | $173 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $171 |
| SCPHARMACEUTICALS INC. | 8 | $157 |
| Novo Nordisk Inc | 2 | $149 |
| Merck Sharp & Dohme LLC | 9 | $145 |
| Abbott Laboratories | 1 | $143 |
| Amgen Inc. | 4 | $84 |
| Novartis Pharmaceuticals Corporation | 4 | $76 |
| PFIZER INC. | 4 | $72 |
Products named: LOKELMA, Kerendia, CAMZYOS, FUROSCIX, AMPLATZER AMULET, FARXIGA, VERQUVO, Ozempic.
Industry payments across TX — which companies pay providers there.
